US SEC Trading Suspension Halt Orders — August 27, 2026

Received a third deficiency letter for failing to file two quarterly reports, despite curing its annual report delinquency. The compliance plan deadline is September 4, 2026, with a final exception limited to October 12, 2026. The repeated failures signal deep operational and reporting issues

Stock closed below $1.00 for 30 consecutive days, triggering a delisting notice. The company has 180 days (until Feb 17, 2027) to regain compliance. No insider buying or positive catalysts were disclosed, suggesting management lacks conviction in a near-term recovery

Received an additional deficiency for failing the $2.5M stockholders' equity requirement, compounding a prior bid price deficiency. The company is ineligible for a 180-day cure period due to cumulative reverse stock splits exceeding 1-for-250, making this a high-risk delisting scenario

Director Ford Fay resigned from the board effective August 21, 2026, the same day the additional deficiency letter was received. Insider departures during a compliance crisis are a strong negative signal

Regained compliance with the minimum bid price requirement after a reverse stock split, with its stock closing at or above $1.00 for 12 consecutive days. This is a positive signal for continued listing, though the reliance on a split is a structural concern

CEO Dominic Wells explicitly attributed compliance to the reverse stock split, allowing the company to refocus on its growth and acquisition strategy. This forward-looking statement suggests management is prioritizing M&A, which could be a catalyst if executed well

The company has a history of repeated delinquency letters (April 17, May 21, and now August 20, 2026), indicating a systemic failure in financial reporting. This pattern increases the likelihood of eventual delisting

The company may be eligible for an additional compliance period if it meets other listing standards, but there is no assurance. This uncertainty creates a binary risk for shareholders

Faces a hard deadline of September 15, 2026, to complete a business combination with Clean World Ventures, Inc. and demonstrate compliance with Nasdaq's Initial Listing Rules. Failure will result in immediate suspension and delisting

Cumulative reverse stock splits of 1-for-1100 over two years (1-for-110 in Oct 2024 and 1-for-10 in Apr 2025) have destroyed shareholder value and made the company ineligible for standard compliance periods. This is a red flag for governance and capital structure

The company has failed to file its Form 10-Q for two consecutive quarters (March 31 and June 30, 2026). This is a pattern of non-compliance that erodes investor trust and could lead to a trading suspension

The stock has traded below $1.00 for 30 consecutive days with no disclosed catalyst for recovery. Without insider buying or a strategic announcement, the risk of delisting remains elevated

The company failed the $2.5M stockholders' equity requirement and also does not meet the alternatives of market value of listed securities or net income from continuing operations. This indicates severe financial distress

The company has only until September 4, 2026, to submit a compliance plan. If rejected, the stock could face immediate suspension. The short timeline is a significant risk

While the company regained compliance, it did so via a reverse stock split. This is a temporary fix and does not address underlying business fundamentals. A future decline could trigger another deficiency

Director Ford Fay resigned on the same day as the additional deficiency letter, suggesting potential internal conflict or loss of confidence in management's ability to navigate the crisis

The company has successfully regained compliance and can now focus on its growth and acquisition strategy. If management executes on M&A, the stock could re-rate as the delisting overhang is removed

CEO Dominic Wells' forward-looking statement about refocusing on growth and acquisitions provides a catalyst for investors to monitor. Any announced deal could drive significant upside

The company has until February 17, 2027, to regain compliance. If the company announces positive clinical data or a strategic partnership, the stock could rally above $1.00, creating a trading opportunity

The company has a hearing scheduled and a stay of delisting until September 15, 2026, contingent on completing a business combination with Clean World Ventures, Inc. If the deal closes, the stock could see a significant re-rating as it meets initial listing requirements

The company has until September 4, 2026, to submit a compliance plan. If the plan is accepted and the company demonstrates a path to filing its delinquent reports, the stock could recover from distressed levels

The company successfully filed its Form 10-K for FY2025 on July 10, 2026, curing that delinquency. This shows some ability to resolve reporting issues, which could be a positive signal if the quarterly reports are filed soon

The company has common stock (ONFO), warrants (ONFOW), and preferred stock (ONFOP) trading on different venues. The warrants could offer leveraged upside if the stock continues to trade above $1.00

3 out of 4 companies received delisting or deficiency notices in the same week, indicating a broader trend of micro-cap companies struggling to maintain listing standards. This is a red flag for the sector and may signal a tightening of regulatory enforcement

Both SOBR Safe and Onfolio Holdings used reverse stock splits to address bid price deficiencies. While Onfolio's split was successful, SOBR Safe's cumulative splits (1-for-1100) made it ineligible for further grace periods, highlighting the diminishing returns of this strategy

Lottery.com's repeated delinquency letters (three in four months) suggest a systemic issue with financial reporting infrastructure in micro-cap companies. This could be a broader sector issue, as small companies often lack the resources to maintain compliance

The resignation of director Ford Fay at SOBR Safe on the same day as the additional deficiency letter is a strong negative signal. In contrast, Onfolio's CEO made a public statement of confidence, though no insider buying was disclosed. The lack of insider buying across all distressed companies is notable

None of the four companies announced dividends, buybacks, or capital returns. All capital allocation efforts are directed toward compliance and survival, reflecting a sector-wide cash preservation mode

The company must present its views to the Hearing Panel by August 28, 2026. The outcome will determine if the stay of delisting continues beyond September 15, 2026

The company must complete its business combination with Clean World Ventures, Inc. by September 15, 2026, to avoid delisting. Any delay or failure will be a major negative catalyst

The company has until September 4, 2026, to submit a compliance plan to Nasdaq. The staff's decision will be critical for the stock's near-term fate

The company must file its Form 10-Qs for March 31 and June 30, 2026, to fully cure its deficiencies. Any filing delays beyond the compliance plan deadline could trigger suspension

The stock must close at or above $1.00 for 10 consecutive business days to regain compliance. Watch for any volume spikes or news that could drive the price above this threshold

CEO Dominic Wells stated the company will refocus on its growth and acquisition strategy. Any M&A announcement could be a positive catalyst for the stock

Following director Ford Fay's resignation, watch for any additional board departures or the appointment of new directors, which could signal the company's ability to navigate the compliance process

The company may be eligible for an additional 180-day period if it meets other listing standards. Watch for any Nasdaq communication regarding this eligibility